Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies

Overview of attention for article published in BMC Rheumatology, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 12 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Tofacitinib Improves Dactylitis Symptoms in Patients With Psoriatic Arthritis

Rheumatology Advisor, 20 Sep 2022

Tofacitinib was beneficial for dactylitis in patients with psoriatic arthritis (PsA) who demonstrated sustained improvements…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.